Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | SPR | P35270 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14516286 | 0.83 | RECQL (0.41) | TSHRRECQLNPSR1SPRHPGD | |
| SCHEMBL23135465 | 0.81 | RECQL (0.61) | TSHRRECQLNPSR1MGAMGAA | |
| SCHEMBL2252214 | 0.81 | EGLN1 (0.52) | TSHRRECQLNPSR1SPRHPGD | |
| SCHEMBL23612487 | 0.80 | TSHR (0.37) | TSHRRECQLNPSR1MGAMGAA | |
| SCHEMBL25839537 | 0.80 | TSHR (0.39) | TSHRRECQLNPSR1SPRHPGD | |
| SCHEMBL3349993 | 0.79 | RECQL (0.39) | TSHRRECQLNPSR1SPRHPGD | |
| SCHEMBL23522323 | 0.79 | RECQL (0.39) | TSHRRECQLNPSR1SPRHPGD | |
| SCHEMBL5194280 | 0.79 | FAAH (0.53) | RECQLGAAHPGDALDH1A1HSD17B10 | |
| SCHEMBL4588095 | 0.79 | SPR (0.40) | TSHRRECQLNPSR1SPRHPGD | |
| SCHEMBL13033131 | 0.78 | RECQL (0.48) | TSHRRECQLMGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346951-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | YALE UNIVERSITY | 2023-11-02 | — | — | US | disclosed |
| WO-2020141223-A1 | INDUCTION OF SUSTAINED LOCAL INFLAMMATION | ASCENDIS PHARMA A/S (DK) | 2020-07-09 | — | — | WO | disclosed |
| US-10039737-B2 | Multi-arm polymeric alkanoate conjugates | NEKTAR THERAPEUTICS (US) | 2018-08-07 | — | — | US | disclosed |
| US-20180092915-A1 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | PARION SCIENCES, INC. (US) | 2018-04-05 | — | — | US | disclosed |
| US-9849129-B2 | Sodium channel blockers for skin disorders | PARION SCIENCES, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-20170252350-A1 | SMALL MOLECULE IRE1-ALPHA INHIBITORS | CORNELL UNIVERSITY | 2017-09-07 | — | — | US | disclosed |
| US-20170189369-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | NEKTAR THERAPEUTICS | 2017-07-06 | — | — | US | disclosed |
| US-20170020870-A1 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | PARION SCIENCES, INC. | 2017-01-26 | — | — | US | disclosed |
| US-9504755-B2 | Multi-arm polymeric alkanoate conjugates | NEKTAR THERAPEUTICS (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160144045-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | NEKTAR THERAPEUTICS | 2016-05-26 | — | — | US | disclosed |
| US-20160017015-A1 | GLYCO-MODIFIED ATRIAL NATRIURETIC PEPTIDE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-01-21 | — | — | US | disclosed |
| US-9220790-B2 | Multi-arm polymeric alkanoate conjugates | NAKTAR THERAPEUTICS (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150133534-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | NEKTAR THERAPEUTICS | 2015-05-14 | — | — | US | disclosed |
| US-8962566-B2 | Multi-arm polymeric alkanoate conjugates | NEKTAR THERAPEUTICS (US) | 2015-02-24 | — | — | US | disclosed |
| US-20140113961-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | NEKTAR THERAPEUTICS (US) | 2014-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170252350-A1 | SMALL MOLECULE IRE1-ALPHA INHIBITORS | XBP1, ERN1, ERN2 | TSHR 4101/4885RECQL 1226/4885NPSR1 4722/4885 |
| US-20170189369-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | ALK, ALKBH3, PAICS | TSHR 3891/4885RECQL 3438/4885NPSR1 3035/4885 |
| US-20180092915-A1 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | SCNN1B, SCNN1A, SCNN1G | TSHR 2482/4885RECQL 585/4885NPSR1 1199/4885 |
| US-20140113961-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | ALK, ALKBH3, PAICS | TSHR 3891/4885RECQL 3438/4885NPSR1 3035/4885 |
| US-20230346951-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | ASGR1, MSR1, LDLR | TSHR 478/4885RECQL 3851/4885NPSR1 171/4885 |
| US-20160017015-A1 | GLYCO-MODIFIED ATRIAL NATRIURETIC PEPTIDE | NPPA, NPR1, NPR3 | TSHR 1619/4885RECQL 4651/4885NPSR1 111/4885 |
| US-20160144045-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | ALK, ALKBH3, PAICS | TSHR 3891/4885RECQL 3438/4885NPSR1 3035/4885 |
| US-20170020870-A1 | SODIUM CHANNEL BLOCKERS FOR SKIN DISORDERS | SCNN1B, SCNN1A, SCNN1G | TSHR 2482/4885RECQL 585/4885NPSR1 1199/4885 |
| US-20150133534-A1 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | ALK, ALKBH3, PAICS | TSHR 3891/4885RECQL 3438/4885NPSR1 3035/4885 |
| US-10039737-B2 | Multi-arm polymeric alkanoate conjugates | ALK, ALKBH3, PAICS | TSHR 3891/4885RECQL 3438/4885NPSR1 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.